Suppr超能文献

心脏手术的 ACEF II 风险评分:更新但仍简洁。

The ACEF II Risk Score for cardiac surgery: updated but still parsimonious.

机构信息

Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, Via Morandi 30, 20097 San Donato Milanese (Milan), Italy.

Department of Medical Biotechnologies, Anesthesia and Intensive Care, University Hospital Santa Maria alle Scotte, Viale Bracci,16-53100 Siena, Italy.

出版信息

Eur Heart J. 2018 Jun 14;39(23):2183-2189. doi: 10.1093/eurheartj/ehx228.

Abstract

AIMS

The age, creatinine, and ejection fraction (ACEF) score was introduced in 2009 and is presently included in the guidelines for myocardial revascularization of the European Society of Cardiology and Association for Cardio-Thoracic Surgery as a risk stratification tool for surgical and percutaneous myocardial revascularization. The present study introduces an updated version of the ACEF (ACEF II) inclusive of emergency surgery and pre-operative anaemia.

METHODS AND RESULTS

The development series includes 7011 consecutive cardiac surgery patients operated at a single institution. The validation series includes 1687 consecutive cardiac surgery patients operated in a different institution. The five factors included in the ACEF II were assessed in a multivariable logistic regression model testing their independent role as predictors of operative (in hospital or 30 days after surgery) mortality. Based on the odds ratio of each predictor, the ACEF II score is calculated as age(years)/ejection fraction (%). Additional points are attributed to a serum creatinine level > 2 mg/dL (2 points), emergency surgery (3 points) and anaemia [haematocrit (HCT) < 36%, 0.2 points per each HCT point below 36%]. The final model was well calibrated. Discrimination of the ACEF II (c-statistics 0.814) was significantly (P = 0.041) better than the ACEF (c-statistics 0.773) and equal to the EuroSCORE II. In the external validation, the ACEF II confirmed a better discrimination than the ACEF and good calibration properties.

CONCLUSION

The ACEF II allows the inclusion of emergency patients and, through a re-modulation of the coefficients and the inclusion of anaemia, appears more adequate to the present cardiac surgery scenario.

摘要

目的

ACEF 评分于 2009 年提出,目前被纳入欧洲心脏病学会和心血管外科学会的心肌血运重建指南,作为手术和经皮心肌血运重建的风险分层工具。本研究引入了 ACEF 的更新版本(ACEF II),包括急诊手术和术前贫血。

方法和结果

开发系列包括在一家机构进行的 7011 例连续心脏手术患者,验证系列包括在另一家机构进行的 1687 例连续心脏手术患者。ACEF II 中包含的五个因素在多变量逻辑回归模型中进行评估,以测试它们作为手术(住院期间或手术后 30 天内)死亡率的独立预测因素的作用。根据每个预测因子的优势比,计算 ACEF II 评分作为年龄(岁)/射血分数(%)。血清肌酐水平>2mg/dL(2 分)、急诊手术(3 分)和贫血[血细胞比容(HCT)<36%,每低于 36%HCT 点 0.2 分]则会额外加分。最终模型具有良好的校准。ACEF II 的区分度(c 统计量 0.814)明显优于 ACEF(c 统计量 0.773),与 EuroSCORE II 相当。在外部验证中,ACEF II 证实了比 ACEF 更好的区分度和良好的校准特性。

结论

ACEF II 允许纳入急诊患者,并通过重新调整系数和纳入贫血,使其更适合当前的心脏手术情况。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验